findmyKOL

Anne Norris, MD

Basic profile

Penn Presbyterian Medical Center

ORCIDNone on fileNPI
RegionPhiladelphia, PA · NortheastSpecialtyInfectious DiseaseFocusInfectious Disease
Last active 2021findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding2020–2021Why? →

Anne Norris is an Infectious Disease physician affiliated with Penn Presbyterian Medical Center. OpenAlex indexes 26 publications with 919 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
26publications

Distinct works indexed by OpenAlex.

919citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
1NIH grants · 2020–2021

Federally funded research awards.

View funding

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    51%
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor12.3%
    Descovy54%Triumeq31%Abacavir8%Emtricitabine-Tenofovir Disop7%
    Part D<11 patients
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor9.8%
    Tivicay66%Cabenuva21%Juluca12%
    Part D<11 patients

    + 11 more classes in this area

  • Cardiovascular

    27.4%
    Statin10.6%
    Rosuvastatin Calcium82%Atorvastatin Calcium10%Lovastatin8%
    Part D<11 patients
    Calcium channel blocker5%
    Amlodipine Besylate100%
    Part D<11 patients

    + 7 more classes in this area

  • Nervous system

    6.9%
    SSRI2.4%
    Citalopram Hbr57%Paroxetine Hcl43%
    Part D<11 patients
    Nonsteroidal Anti-inflammatory Drug2.3%
    Ibuprofen100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20202021 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”